全文获取类型
收费全文 | 656篇 |
免费 | 50篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 35篇 |
妇产科学 | 33篇 |
基础医学 | 79篇 |
口腔科学 | 27篇 |
临床医学 | 95篇 |
内科学 | 158篇 |
皮肤病学 | 15篇 |
神经病学 | 13篇 |
特种医学 | 79篇 |
外科学 | 44篇 |
综合类 | 26篇 |
一般理论 | 1篇 |
预防医学 | 66篇 |
眼科学 | 1篇 |
药学 | 26篇 |
中国医学 | 3篇 |
肿瘤学 | 16篇 |
出版年
2023年 | 5篇 |
2021年 | 6篇 |
2020年 | 7篇 |
2019年 | 10篇 |
2018年 | 11篇 |
2017年 | 6篇 |
2016年 | 13篇 |
2015年 | 6篇 |
2014年 | 13篇 |
2013年 | 19篇 |
2012年 | 10篇 |
2011年 | 14篇 |
2010年 | 25篇 |
2009年 | 29篇 |
2008年 | 24篇 |
2007年 | 33篇 |
2006年 | 20篇 |
2005年 | 18篇 |
2004年 | 29篇 |
2003年 | 20篇 |
2002年 | 17篇 |
2001年 | 15篇 |
2000年 | 7篇 |
1999年 | 13篇 |
1998年 | 35篇 |
1997年 | 31篇 |
1996年 | 34篇 |
1995年 | 28篇 |
1994年 | 18篇 |
1993年 | 23篇 |
1992年 | 8篇 |
1991年 | 8篇 |
1990年 | 19篇 |
1989年 | 19篇 |
1988年 | 16篇 |
1987年 | 20篇 |
1986年 | 12篇 |
1985年 | 8篇 |
1984年 | 6篇 |
1983年 | 5篇 |
1982年 | 5篇 |
1980年 | 6篇 |
1977年 | 7篇 |
1976年 | 5篇 |
1975年 | 4篇 |
1973年 | 3篇 |
1972年 | 3篇 |
1971年 | 4篇 |
1969年 | 3篇 |
1967年 | 3篇 |
排序方式: 共有718条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
7.
The rate of alloimmunization to platelet-specific antigens associated with platelet glycoproteins (GPs) IIb-IIIa and Ib/IX was studied in 293 multiply transfused thrombocytopenic patients. Antibodies to platelet-specific antigens were measured with a solid-phase assay using platelet GP IIb-IIIa or Ib/IX as the antigenic targets. Nine patients were found to have antibodies to platelet GP IIb-IIIa, and no patients had antibodies to platelet GP Ib/IX. In six of these nine patients, the specificity of the antibody was shown by using GP IIb-IIIa from donors with different platelet-specific antigen phenotypes. In the remaining three patients with antibodies to platelet GP IIb-IIIa, no specificity could be identified. These patients had autoimmune thrombocytopenia in association with lymphoma. The alloimmunization rate to platelet-specific antigens associated with GP IIb-IIIa was 2 percent, whereas the rate of alloimmunization to HLA antigens was 23 percent. Of the patients alloimmunized to HLA antigens, 9 percent also had antibodies to platelet-specific antigens. A poor response to HLA-identical platelet transfusions was observed only in those patients with positive assays in the solid-phase test. These results suggest that the incidence of antibodies to platelet-specific antigens carried on GP IIb-IIIa is low. Platelet-specific antibodies may be found more frequently in patients alloimmunized to HLA antigens than in those not so alloimmunized. 相似文献
8.
Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety 总被引:1,自引:0,他引:1
Noble M Tregear SJ Treadwell JR Schoelles K 《Journal of pain and symptom management》2008,35(2):214-228
Opioid therapy for chronic noncancer pain (CNCP) is controversial due to concerns regarding long-term efficacy and adverse events (including addiction). We systematically reviewed the clinical evidence on patients treated with opioids for CNCP for at least six months. Of 115 studies identified by our search of eleven databases (through April 7, 2007), 17 studies (patients [n]=3,079) met inclusion criteria. Studies evaluated oral (studies [k]=7; n=1,504), transdermal (k=3; n=1, 993), and/or intrathecal (k=8; n=177) opioids. Many patients withdrew from the clinical trials due to adverse effects (oral: 32.5% [95% confidence interval (CI), 26.1%-39.6%]; intrathecal: 6.3% [95% CI, 2.9%-13.1%]; transdermal: 17.5% [95% CI, 6.5%-39.0%]), or due to insufficient pain relief (oral: 11.9% [95% CI, 7.8%-17.7%]; intrathecal: 10.5% [95% CI, 3.5%-27.4%]; transdermal: 5.8% [95% CI, 4.2%-7.3%]). Signs of opioid addiction were reported in only 0.05% (1/2,042) of patients and abuse in only 0.43% (3/685). There was an insufficient amount of data on transdermal opioids to quantify pain relief. For patients able to remain on oral or intrathecal opioids for at least six months, pain scores were reduced long-term (oral: standardized mean difference [SMD] 1.99, 95% CI, 1.17-2.80; intrathecal: SMD 1.33, 95% CI, 0.97-1.69). We conclude that many patients discontinue long-term opioid therapy due to adverse events or insufficient pain relief; however, weak evidence suggests that oral and intrathecal opioids reduce pain long-term in the relatively small proportion of individuals with CNCP who continue treatment. 相似文献
9.
10.
Timothy W. Farrell MD AGSF Leslie Francis PhD JD Teneille Brown JD Lauren E. Ferrante MD MHS Eric Widera MD Ramona Rhodes MD MPH MSCS AGSF Tony Rosen MD MPH Ula Hwang MD MPH Leah J. Witt MD Niranjan Thothala MD MRCP MBA Shan W. Liu MD SD Caroline A. Vitale MD AGSF Ursula K. Braun MD MPH Caroline Stephens PhD RN GNP-BC Debra Saliba MD MPH AGSF 《Journal of the American Geriatrics Society》2020,68(6):1143-1149
Coronavirus disease 2019 (COVID-19) continues to impact older adults disproportionately with respect to serious consequences ranging from severe illness and hospitalization to increased mortality risk. Concurrently, concerns about potential shortages of healthcare professionals and health supplies to address these issues have focused attention on how these resources are ultimately allocated and used. Some strategies, for example, misguidedly use age as an arbitrary criterion that disfavors older adults in resource allocation decisions. This is a companion article to the American Geriatrics Society (AGS) position statement, “Resource Allocation Strategies and Age-Related Considerations in the COVID-19 Era and Beyond.” It is intended to inform stakeholders including hospitals, health systems, and policymakers about ethical considerations that should be considered when developing strategies for allocation of scarce resources during an emergency involving older adults. This review presents the legal and ethical background for the position statement and discusses these issues that informed the development of the AGS positions: (1) age as a determining factor, (2) age as a tiebreaker, (3) criteria with a differential impact on older adults, (4) individual choices and advance directives, (5) racial/ethnic disparities and resource allocation, and (6) scoring systems and their impact on older adults. It also considers the role of advance directives as expressions of individual preferences in pandemics. J Am Geriatr Soc 68:1143–1149, 2020. 相似文献